Form 8-K · Current report
Corteva 8-K, filed Sep 21, 2026
- Filed
- CIK
- 0001755672
- Accession no.
- 0001193125-26-396123
Summary
Corteva subsidiary Vylor, Inc. filed Amendment No. 3 to its Form 10 registration statement with the U.S. Securities and Exchange Commission in connection with Corteva's previously announced plan to separate its seed operating segment into an independent publicly traded company, Vylor Inc. The filing provides detailed information on Vylor's business, strategy, and historical financial results.
Key points
- Vylor, Inc. filed Amendment No. 3 to its Registration Statement on Form 10 on September 21, 2026.
- The filing relates to Corteva's previously announced plan to separate into two independent, publicly traded companies through the separation of Corteva's seed operating segment into Vylor Inc.
- The amendment provides detailed information on Vylor's business, strategy, and historical financial results.
- Corteva and Vylor stated that the separation is subject to risks and uncertainties, including whether it will be consummated at all.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
From the filing
Item 7.01 Regulation FD Disclosure On September 21, 2026, Vylor, Inc., a subsidiary of Corteva, Inc. (“Corteva” or the “Company”) filed its Amendment No. 3 to the Registration Statement on Form 10 (File No. 001-43376) with the U.S. Securities and Exchange Commission in connection with Corteva’s previously announced plans of a separation of Corteva into two independent, publicly traded companies through the separation of Corteva’s seed operating segment into an independent, publicly traded company, Vylor Inc. (“Vylor”). The filing provides detailed information on Vylor’s business, strategy and historical financial results. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.